Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Omar Green
Chief Executive Officer

Message the company or request a 1:1 meeting here

Ionica Sciences is addressing a key absence in the clinicians diagnostic tool box: diseases that are not well addressed by PCR testing, often referred to as molecular testing, or immunoassays, often referred to as antigen testing. By addressing this class of diseases, which include Lyme disease and traumatic brain injury (TBI), Ionica hopes to prevent the potential lifelong debilitating consequences of mis- or missed diagnoses for these, and related, diseases.

Pitch Video

Slide Deck